Free Trial
OTCMKTS:NHNKY

Nihon Kohden 11/8/2023 Earnings Report

Nihon Kohden logo
$11.50 -0.55 (-4.52%)
As of 03:08 PM Eastern

Nihon Kohden EPS Results

Actual EPS
$0.17
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nihon Kohden Revenue Results

Actual Revenue
$379.33 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nihon Kohden Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Nihon Kohden's next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules.

Conference Call Resources

Nihon Kohden Earnings Headlines

Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
See More Nihon Kohden Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nihon Kohden? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nihon Kohden and other key companies, straight to your email.

About Nihon Kohden

Nihon Kohden (OTCMKTS:NHNKY) engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

View Nihon Kohden Profile

More Earnings Resources from MarketBeat